Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan

Shock

Volumn 15, Issue 3, 2001, Pages 181-185

  Ombrellino, Michael ^a   Wang, Haichao ^a   Yang, Huan ^a   Zhang, Minghuang ^b   Vishnubhakat, Jaideep ^b   Frazier, Asia ^a   Scher, Larry A ^a   Friedman, Steven G ^a   Tracey, Kevin J ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

Alpha 2 HS glycoprotein; Anti inflammatory; Edema; Spermine

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA FETOPROTEIN; CARRAGEENAN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; EDEMA; IMMUNOLOGY; INFLAMMATION; LEWIS RAT; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT;

ACUTE-PHASE PROTEINS; ALPHA-FETOPROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; INFLAMMATION; MALE; RATS; RATS, INBRED LEW; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035293988     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115030-00004     Document Type: Article

References (25)

1. Otterness IV, Moore PF: Carrageenan foot edema test. Methods Enzymol 162: 320-327, 1988.
2. Blanchi M, Ulrich P, Bloom O, Meistrell III M, Zimmerman GA, Schmidt-mayerova H, Bukrinsky M, Donnelley T, Bucala R, Sherry B, et al.: An inhibitor of arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol Med 1:254-266, 1995.
3. Ianaro A, O'Donnell CA, Di Rosa M, Liew FY: A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenan-induced edema in mice. Immunology 82:370-375, 1994.
4. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD, et al.: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
5. Oswald IP, Wynn TA, Sher A, James SL: Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor a required as a costimulatory factor for interferon-γ-induced activation. Proc Natl Acad Sci USA 89:8676-8680, 1993.
6. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290, 1995.
7. Zhang M, Caragine T, Wang H, Cohen PS, Botchkina G, Soda K, Blanchi M, Ulrich P, Cerami A, Sherry B, Tracey KJ: Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counter-regulatory mechanism that restrains the immune response. J Exp Med 185:1-10, 1997.
8. Tsunawaki S, Sporn M, Ding A, Nathan CF: Deactivation of macrophages by transforming growth factor-β. Nature 334:260-262, 1988.
9. Donnelly RP, Freeman SL, Hayes MP: Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes. J Immunol 155: 1420-1427, 1995.
10. Pedersen KO: Fetuin, a new globulin isolated from serum. Nature 154:575-576, 1944.
11. Dziegielewska KM, Brown WM, Casey SJ, Christie DL, Foreman RC, Hill RM, Saunders NR: The complete cDNA and amino acid sequence of bovine fetuin: its homology with α2HS glycoprotein and relation to other members of the cystatin superfamily. J Biol Chem 265:4354-4357, 1990.
12. Lee CC, Bowman BH, Yang FM: Human α2-HS-glycoprotein: the A and B chains with a connecting sequence are encoded by a single mRNA transcript. Proc Natl Acad Sci USA 84:4403-4407, 1987.
13. Christie DL, Dziegielewska KM, Hill RM, Saunders NR: Fetuin: the bovine homologue of human α 2HS glycoprotein. FEBS Lett 214:45-49, 1987.
14. Banine F, Gangneux C, Lebreton JP, Frebourg T, Salier JP: Structural and functional analysis of the 5′-transcription control region for the human α2-HS glycoprotein gene. Biochim Biophys Acta 1398:1-8, 1998.
15. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G: Serum concentration of human α-2-HS glycoprotein during the inflammatory process: evidence that α-2-HS glycoprotein is a negative acute-phase reactant. J Clin Investig 64:1118-1129, 1979.
16. Jahnen-Dechent W, Schinke T, Trindl A, Muller-Esterl W, Sablitzky F, Kaiser S, Blessing M: Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272:31496-31503, 1997.
17. Wang H, Zhang M, Soda K, Sama A, Tracey KJ: Fetuin protects the fetus from TNF. Lancet 350:861-862, 1997.
18. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ: Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophage deactivating molecules. Proc Natl Acad Sci USA 95:14429-14434, 1998.
19. Dziegielewska KM, Andersen NA: The fetal glycoprotein, fetuin, counteracts Ill-effects of the bacterial endotoxin, lipopolysaccharide, in pregnancy. Biol Neonate 74:372-375, 1998.
20. Daveau M, Christian-Davrinche Julen N, Hiron M, Arnaud P, Lebreton JP: The synthesis of α-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells. FEBS Lett 241:191-194, 1988.
21. Brown WM, Saunders NR, Mollgard K, Dziegielewska KM: Fetuin: an old friend revisited. Bioessays 14:749-755, 1992.
22. Dziegielewska KM, Andersen NA, Saunders NR: Modification of macrophage response to lipopolysaccharide by fetuin. Immunol Lett 60:31-35, 1998.
23. Chertov OY, Ermolaeva MV, Satpaev DK, Saschenko LP, Kabanova OD, Lukanidin EM, Lukjianova TI, Redchenko IV, Blishchenko LY, Gnuchev NV: Inhibitory effect of calf fetuin on the cytotoxic activity of LAK cell-derived factors and tumor necrosis factor, Immunol Lett 42:97-100, 1994.
24. Rohrlich ST, Rifkin DB: Isolation of the major serine protease inhibitor from the 5-day serum-free conditioned medium of human embryonic lung cells and demonstration that it is fetuin. J Cell Physiol 109:1-15, 1981.
25. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251.